Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/24 17:59 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Perry Andrew | NC | O | Chief Co | 1 | S | -3 | 2.51 | 0 | -1 | 113 | D | |||||||||||||||
7/8/24 17:58 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Murdock Terry L | NC | O | COO | 1 | S | -6 | 2.51 | 0 | -2 | 128 | D | |||||||||||||||
7/8/24 17:57 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Malik Rajesh | NC | O | Chief Me | 1 | S | -6 | 2.51 | 0 | -2 | 159 | D | |||||||||||||||
7/8/24 17:55 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Avagliano Mark | NC | O | Chief Bu | 1 | S | -7 | 2.51 | 0 | -3 | 242 | D | |||||||||||||||
7/8/24 17:54 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Umstead John W. V | NC | O | CFO | 1 | S | -1 | 2.51 | 0 | -1 | 0 | 188 | D | ||||||||||||||
7/8/24 17:53 | 7/5/24 | GTHX | Health | Drug | Pharmaceutical Preparations | Bailey John E. (Jack) Jr. | NC | DO | P,CEO | 1 | S | -19 | 2.51 | 0 | -8 | 550 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |